🔎 Trials Near Me

Home › Myelodysplastic Syndromes › Florida › Tampa

Myelodysplastic Syndromes clinical trials in Tampa, FL

19 studies for Myelodysplastic Syndromes are looking for participants at sites in and around Tampa (within about 30 miles). Open a study to see who can join and how to contact the study team.

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RecruitingPhase 2
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05564390

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

RecruitingPhase 1/2
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT05320198

A Study of BGB-11417 in Participants With Myeloid Malignancies

RecruitingPhase 1/2
  • Tampa General Hospital, Tampa
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT04771130

A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)

RecruitingPhase 1
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06616636

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

RecruitingPhase 2
  • H. Lee Moffitt Cancer Center and Research Center, Tampa
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT04419649

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

RecruitingPhase 3
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT06499285

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

RecruitingPhase 1
  • H Lee Moffitt Cancer Center & Research Institute, Tampa
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06656494

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

RecruitingPhase 2
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Jul 7, 2026 · NCT07216443

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

RecruitingPhase 1
  • Moffitt Cancer Center, Tampa
Ages 12 to 78 · All sexes · Updated Jul 1, 2026 · NCT03802695

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

RecruitingPhase 1/2
  • Moffitt Cancer Center, Tampa
Ages 12 and older · All sexes · Updated Mar 24, 2026 · NCT04988555

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

RecruitingPhase 2
  • Moffitt Cancer Center, Tampa
Ages 1 to 60 · All sexes · Updated Mar 12, 2026 · NCT03970096

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

RecruitingPhase 1
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Jan 16, 2026 · NCT05143996

Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome

RecruitingPhase 1
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Dec 23, 2025 · NCT04245397

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Tampa
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

RecruitingPhase 1
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Sep 24, 2025 · NCT06501196

Study of REM-422 in Patients With AML or Higher Risk MDS

RecruitingPhase 1
  • Moffitt Cancer Center, Tampa
Ages 18 and older · All sexes · Updated Apr 23, 2025 · NCT06297941

A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)

RecruitingPhase 1/2
  • H. Lee Moffitt Cancer Center & Research Institute, Tampa
Ages 18 and older · All sexes · Updated Apr 8, 2019 · NCT03886662

About Myelodysplastic Syndromes

Myelodysplastic Syndromes (MDS) are rare. They are sometimes found during a routine blood test. Learn symptoms, risk factors, and treatment options.

More about Myelodysplastic Syndromes on MedlinePlus

Myelodysplastic Syndromes trials in other cities

Other studies in Tampa

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.